Why CAMP4?
Leadership
Investors
About Our Name
RAP Platform
Reg Actuators
Programmable Therapeutics
Publications & Presentations
Pipeline
Newsroom
Join the Adventure
Recent News
September 5, 2023
CAMP4 Therapeutics to Present at Upcoming Industry and Investor Conferences
Read More
March 21, 2024
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders
Read More
Contact Us
Privacy Policy
Menu
Newsroom
Views and missives from the frontier
All
Press Releases
Perspectives
In the News
Videos
July 13, 2021
Press Releases
CAMP4 Therapeutics Expands Leadership and Board of Directors
June 15, 2021
Press Releases
CAMP4 Raises $45 Million to Usher in a New Era of Programmable Therapeutics to Upregulate Genes
October 29, 2019
Press Releases
CAMP4 Therapeutics Expands Board of Directors with Appointment of Steven Holtzman as Chair and Dr. Paula Ragan as Director
October 25, 2019
Press Releases
Richard Young, Ph.D., Founder of CAMP4 Therapeutics, Elected to National Academy of Medicine
May 31, 2018
Press Releases
CAMP4 Therapeutics Launches with Platform to Discover Effective Treatment Approaches for Every Disease, Announces $30 Million Series A Financing
«
1
2
Media Contact:
PR@camp4tx.com
Top